Innovations in repetitive transcranial magnetic stimulation: a review of clinical evidence and patient-reported outcomes for ExoTMS - Summary - MDSpire
Advertisement
Advancements in Repetitive Transcranial Magnetic Stimulation: An Overview of Clinical Evidence and Patient Feedback on ExoTMS
To examine the technological characteristics, safety profile, and therapeutic implications of ExoTMS, focusing on patient-reported outcomes, treatment comfort, and safety.
Approach:
Study Inclusion: Eight studies were included, involving 182 active-treated participants receiving stimulation at effective intensity levels.
Treatment Protocols: Participants underwent 4 to 6 sessions, with follow-up assessments at 1 month and, where applicable, at 3 months post-treatment.
Data Collection: Data included mapping time for coil positioning, incidence of adverse events, and patient-reported outcomes on treatment satisfaction and perceived comfort.
Key Findings:
Patients reported high satisfaction with ExoTMS treatment, with improvements observed immediately post-treatment and at follow-up.
Improvements were noted across multiple domains, including overall well-being, mood, perceived stress, and mental energy.
93.3% of participants reported the therapy as comfortable with minimal to no pain.
No serious adverse events were reported.
Interpretation:
ExoTMS is a well-tolerated intervention with favorable treatment comfort and safety, suggesting potential advantages over conventional TMS systems.
Limitations:
The review is based on a limited number of studies and participants.
Long-term effects beyond 3 months were not assessed.
Conclusion:
ExoTMS may offer practical advantages, including reduced treatment burden and improved clinical workflow efficiency.
by David Pánek, Václav Gerla, Michelle Dees, Yael Halaas, JD McCoy, Louis Cady, Rakesh Nanda, Rudolph Eberwein, Henry Johnston, Nick Tvrdik, Georgine Nanos, Charmi Patel, Melinda Silva